L1 capsomeres as a next generation preventive HPV vaccine
$111,720P50FY2013CANIH
Johns Hopkins University, Baltimore MD
Investigators
Linked publications & trials
Paper 39722048Paper 39472678Paper 39379923Paper 39282286Paper 39164924Paper 38709485Paper 38675812Paper 38649894Paper 38340648Paper 38328193Paper 38287325Paper 38170154Paper 37917174Paper 37826852Paper 37791765Paper 37398082Paper 37290095Paper 37270364Paper 37043646Paper 36925069Paper 36851559Paper 36827841Paper 36787285Paper 36780987Paper 36649341Paper 36607735Paper 36455190Paper 36243868Paper 36224625Paper 36213965Paper 36102632Paper 36070626Paper 36042884Paper 35476298Paper 35459734Paper 35428687Paper 35405716Paper 35359489Paper 35348533Paper 35300052Paper 35294540Paper 35284612Paper 35265742Paper 35141857Paper 35115179Paper 35089069Paper 35028321Paper 34952401Paper 34856576Paper 34856571Paper 34838160Paper 34804041Paper 34723848Paper 34648735Paper 34517865Paper 34506530Paper 34492116Paper 34380620Paper 34215618Paper 34143885Paper 34074808Paper 34018674Paper 33926459Paper 33888488Paper 33855146Paper 33842408Paper 33802456Paper 33596114Paper 33580043Paper 33573433Paper 33476764Paper 33472931Paper 33468698Paper 33309485Paper 33200366Paper 33139904Paper 33108473Paper 33032902Paper 33019516Paper 32951895Paper 32877650Paper 32822525Paper 32817372Paper 32740092Paper 32710745Paper 32528733Paper 32468232Paper 32426032Paper 32375699Paper 32345710Paper 32326356Paper 32295905Paper 31940398Paper 31939072Paper 31870557Paper 31848025Paper 31816512Paper 31771866Paper 31764025Paper 31688005
Abstract
The recent development of prophylactic vaccines protective against
View original record on NIH RePORTER →